Hambro Perks


Hambro Perks leads Aide Health's $1.2 million pre-seed for long-term illness digital care app

Hambro Perks leads Aide Health's $1.2 million pre-seed for long-term illness digital care app

Health-tech startup Aide Health has raised $1.2m in pre-seed funding led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX.

Launched by co-founders Ian Wharton, CEO, and Brian Snyder, COO, Aide is a digital platform that helps patients and their clinicians better understand and manage long-term health conditions, currently affecting over 26 million people in the UK. 

In 50% of cases, people struggle to follow the treatment as prescribed by their clinician, lowering their quality of life and placing added strain on the resources of the health service.

Aide provides clinicians with a platform to create and remotely monitor health plans for people with chronic disease, paired with a mobile app for the patient which acts as a co-pilot through their care. Using natural language, Aide has short, daily conversations to help with the day-to-day management of health conditions through medicines optimisation, structured monitoring and structured education.

The service is currently being used by the NHS, with a pilot launched earlier this year supporting people aged between 18-75 with asthma or type-2 diabetes. Aide has a specific focus on meeting the rising challenge of comorbidity and will soon be launching pathways for hypertension and chronic pain.

Ian Wharton, co-founder and CEO at Aide Health, says: "Like many people, I know first-hand the frustations of tring to manage long-term conditions. Our goals is to give both patients and clinicians the tools and insights they need to have better conversations and make more informated treatment decisions together. The pilot in NHS England is our first step towards making Aide available to everyone with chronic illness".

Nicholas Sharp, Head of Hambro Perks Growth EIS Fund, commented: "Ian and Brian's vision and experience impressed up from the start, and we believe that Aide Health has the potential to be a hugely important tool for both clinicians and patients for managing long-term health conditions. Hambro Perks has a long track record of backing healthtech companies as part of our aim to invest in companies that make the world a better place. Aide Health and Ian's team were therefore an obvious choice for us, and we look forward to supporting them on their growth journey".